Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01590446 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers
A Phase 1 study, sponsored by BioMarin Pharmaceutical.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT01590446 is a Phase 1 study that has completed, run by BioMarin Pharmaceutical. The registered enrollment target is 74 participants.
The verdict
NCT01590446, a Phase 1 study, has completed, sponsored by BioMarin Pharmaceutical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.
Interventions
- DRUG Normal Saline
- DRUG BMN 111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01590446
The ClinicalTrials.gov registry entry for NCT01590446 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMarin Pharmaceutical, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT01590446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01590446 about?
NCT01590446 is a clinical study titled "A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers". The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.
What is the current status of trial NCT01590446?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-02. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01590446?
The interventions under investigation include: Normal Saline (DRUG), BMN 111 (DRUG).
Who is sponsoring clinical trial NCT01590446?
This trial is sponsored by BioMarin Pharmaceutical, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.